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Abstract
Background The number of medication related hospital admissions and readmissions are increasing over the years due to 
the ageing population. Medication related hospital admissions and readmissions lead to decreased quality of life and high 
healthcare costs. Aim of the review To assess what is currently known about medication related hospital admissions, medi-
cation related hospital readmissions, their risk factors, and possible interventions which reduce medication related hospital 
readmissions. Method We searched PubMed for articles about the topic medication related hospital admissions and readmis-
sions. Overall 54 studies were selected for the overview of literature. Results Between the different selected studies there 
was much heterogeneity in definitions for medication related admission and readmissions, in study population and the way 
studies were performed. Multiple risk factors are found in the studies for example: polypharmacy, comorbidities, therapy non 
adherence, cognitive impairment, depending living situation, high risk medications and higher age. Different interventions 
are studied to reduce the number of medication related readmission, some of these interventions may reduce the readmis-
sions like the participation of a pharmacist, education programmes and transition-of-care interventions and the use of digital 
assistance in the form of Clinical Decision Support Systems. However the methods and the results of these interventions 
show heterogeneity in the different researches. Conclusion There is much heterogeneity in incidence and definitions for both 
medication related hospital admissions and readmissions. Some risk factors are known for medication related admissions 
and readmissions such as polypharmacy, older age and additional diseases. Known interventions that could possibly lead to 
a decrease in medication related hospital readmissions are spare being the involvement of a pharmacist, education programs 
and transition-care interventions the most mentioned ones although controversial results have been reported. More research 
is needed to gather more information on this topic.
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Impact on practice
• Medication related admissions and medication related 
readmissions are common, however we still do not know 
enough to reduce them.
• Defining a common definition for medication related 
admissions and medication related readmission may 
ensure less heterogeneity in the future studies.
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Introduction
Thousands of medical interventions are performed each day 
in healthcare to improve the health status of our patients. 
The prescription of medication is an important intervention 
within the medical care for older patients [1, 2]. The rising 
incidence of multimorbidity and consequently polypharmacy 
adds to the complexity of managing older patients in par-
ticular [3]. Inadequate medication management and polyp-
harmacy are important risk factors for adverse drug events 
and drug-drug interactions and frequently lead to hospital 
admissions and hospital readmissions and other undesirable 
consequences such as increased morbidity, decreased self-
reliance and even death [4–7].
The number of acute and medication related hospital 
admissions is increasing over the years due to the ageing 
population [8]. In medication related hospital admissions 
two categories can be distinguished, namely primary admis-
sions and readmissions. Less research is performed in the 
latter category. Both admissions and readmissions account 
for decreased quality of life and high healthcare costs [9, 10].
Aim of the review
To give an overview on what is currently known about medi-
cation related hospital admissions, medication related hos-
pital readmissions, their risk factors, and possible interven-
tions which reduce medication related hospital readmissions.
Methods
Search strategy
We performed an overview of literature but not a system-
atic review. The single data source used was PubMed. We 
searched for articles with a set of MeSH terms and text 
words selected to cover articles on medication related admis-
sions and medication related readmissions. The search was 
limited for articles published in English language. The 
search was performed in February 2017, with no limitations 
with regard to the publication date. We included articles that 
investigated the incidence of medication related admissions 
and medication related readmissions and their risk factors. 
We also included articles that investigated possible inter-
ventions which may reduce the rate of medication related 
readmissions. We selected studies that were performed in 
hospitals. We did not differentiate between hospital types 
for the performed studies. All study designs were allowed. 
The outcomes of the selected articles were dependant of 
the study. It was important that the outcome was related 
to the incidence of the medication related admissions and 
readmissions or their risk factors. Studies which investigated 
possible intervention to reduce the readmissions were also 
included.
We first selected articles based on the title. After the first 
selection two authors (AL and KH) independently assessed 
the articles for usability based on the abstract of the arti-
cles. Excluded were articles investigating an intervention 
or a treatment for a disease in which they had as a primary 
or secondary outcome the readmission rate. The quality of 
the different studies was not an exclusion criteria. When 
there was disagreement on in/exclusion of an article, a third 
reviewer was consulted and consensus was reached.
Results
In total 476 records were retrieved with the PubMed search 
and we selected 12 records through references. Figure 1 
shows the selection of the studies used for this literature 
overview. Overall 54 studies were assessed as relevant for 
the overview of this topic. In most of the excluded articles, 
the objective did not match our topic.
Medication related hospital admissions
Medication related problems are a daily occurrence at the 
emergency department.
However, incidence rates on hospital admissions due to 
medication related problems differ because of the lack of 
a clear definition and the lack of identification which may 
underestimate the problem [11].
The most commonly used definition is an admission due 
to an adverse drug reaction (ADR). ADR is defined as: “a 
response to a drug that is noxious and unintended and occurs 
at doses normally used in man for the prophylaxis, diagnosis 
or therapy of disease, or for modification of physiological 
function” [12].
Another accepted definition of a medication related hos-
pital admission is an admission due to an adverse drug event 
(ADE): “any untoward medical occurrence that may present 
during treatment with a pharmaceutical product but which 
does not necessarily have a causal relationship with this 
treatment” [13].
Finally, medication related hospital admissions are also 
defined as admissions due to drug related problems (DRP) 
[14, 15]. A DRP is defined as an event or circumstance that 
involves a patient’s drug treatment that actually, or poten-
tially, interferes with the achievement of an optimal outcome 
[14–16].
International Journal of Clinical Pharmacy 
1 3
Studies on the incidence of the association between hos-
pital admissions and the presence of an ADR or ADE show 
great variety (0.5–18.9% and 5.6–19.3% respectively) [7, 
10, 17–22].
A possible reason for the wide range of incidences is, 
as mentioned above, the variability in the used definition 
for medication related hospital admissions. Since ADE 
and DRP comprises a broader set of possible problems 
compared to ADR, incidence numbers could be higher. 
Also, patient inclusion criteria differ between studies. 
Some studies include all adults while other studies only 
include patients above 60 years old [10, 17, 19–22]. This 
influences the interpretation and comparability of results.
Furthermore, the type of patients differs between stud-
ies; where some studies include all unplanned admissions, 
other studies only include patients admitted for a specific 
ward [10, 17, 19, 21, 22].
Apart from the different inclusion and exclusion crite-
ria, the study methods are also different. Different kind of 
designs and the selection procedure are used which may 
lead to a lack of identification of a medication related 
admission [17, 19, 21, 23].
In conclusion, there was much heterogeneity between 
studies in study population and the way studies were per-
formed [22]. Although there was great variety in inci-
dence, overall studies showed that medication related hos-
pital admissions are a significant and possible preventable 
cause of unfavourable outcome and high healthcare costs.
Medication related hospital readmissions
A hospital readmission is a second admission to the hospital 
within a certain period of time. In literature, different time 
periods are being used between the hospital discharge and 
readmission, ranging from 30 days to three years. However, 
a period of 30 days is most common [24–29]. Worldwide, 
readmissions are an important indicator for quality of health-
care and is therefore also part of the basic set of quality 
indicators of the Dutch Healthcare inspectorate (IGJ) [30].
As with medication related hospital admissions, differ-
ent definitions of medication related readmissions are being 
used with regard to ADRs, ADEs and DRPs. A common 
definition assumes that medication-related hospital readmis-
sions are readmissions due to problems around pharmaco-
therapy [31]. Different DRPs can occur in patients using 
medication, especially patients with polypharmacy. Exam-
ples for DRPs are problems with medication adherence, 
ADRs, inappropriate drug selection, drug use without indi-
cation, drug-drug interactions, additional therapy needed, 
lack of therapy monitoring, sub-therapeutic dosage and 
supra-therapeutic dosage. All problems in these categories 
can lead to a medication-related hospital readmission [31].
Another definition assumes medication related readmis-
sions based on ADRs and ADEs [24, 32].
Because of the differences in definition, incidences of 
medication related readmissions vary greatly and range from 
0.09% to 64.0% [27–29].
Citaons idenfied through 
PubMed (n= 476) 
Records aer first selecon (n=95)
Studies  included (n=54)
Excluded aer tle  review based on 
the inclusion and exclusion criteria 
(n=393)
Full-text arcles excluded aer abstract and full text 
review  based on the inclusion and exclusion criteria 
(n=41)
- Other subject 
- Study based on one typical intervenon/treatment 
Records idenfied through 
references ( n = 12)
Fig. 1  Flow diagram of the selection of studies for this literature overview
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According to the definition you would expect that the rate 
for medication related readmissions based on ADRs is lower 
compared to ADE. The prevalence for the ADRs related 
hospital admission varies from 0.5 to 18.9% [17–22] and 
for de ADEs related hospital admission varies from 5.6% 
till 19.3% [7, 23].
Besides the variety in definitions used in the studies for 
medication related hospital readmissions, the time between 
discharge and readmission also differs between studies, rang-
ing from 30 days to three years [24–29]. This makes inter-
pretation of the results difficult. To conclude, studies with 
regard to hospital readmissions are also difficult to interpret 
due to differences in study design and definitions used.
Risk factors for medication related admission 
and medication related readmissions
Several risk factors have been identified in medication 
related hospital admissions due to ADE’s. According to 
Leendertse et al. patients with impaired cognition, four or 
more comorbidities, dependent living situation, polyphar-
macy, impaired renal function and/or nonadherence to the 
medication regimen were found to be at greater risk of a 
hospital admission [7, 10]. These risk factors are consist-
ent with other studies performed on this topic [23, 33]. The 
most common drugs associated with (potentially prevent-
able) admissions were anticoagulants, antiplatelet drugs, 
vasodilators, psychotropic medications and diuretics [7, 23, 
33]. Little is known about the risk factors of a medication 
related readmission for older patients but it is likely that 
there is great overlap with the risk factors for medication 
related admissions. Possible additional risk factors are a 
higher Charles comorbidity score and inadequate follow-up 
due to a missed appointment with the successive physician 
[24, 27, 28]. Increased age is also found as a risk factor of 
ADRs or ADPs related readmissions [25, 26].
Some specific medications are also associated with a 
higher incidence of medication related hospital readmis-
sions. The most frequent medications which are associated 
with medication related hospital readmission are antiplatelet 
medications, diuretics, anti-coagulants and anti-hypertensive 
drugs [25, 29]. Zhang et al. found a greater risk for repeated 
ADRs for the drug categories hormones, primarily systemic 
agents (including antineoplastic, immunosuppresses and 
neoplastic antibiotics) and bacterial vaccines, resulting in 
a hospital readmission or an ADR during hospitalisation 
[24]. Alassaad et al. found in patients above 80 years old 
that drugs prescribed for peptic ulcer or gastroesophageal 
reflux disease and opioids are associated with an increased 
risk for readmission, the reason for the readmission was not 
mentioned [34]. Beside a higher risk for medication related 
readmissions due to specific medications, some studies also 
investigate the association between the complexity of the 
medication list and medication related hospital readmis-
sions [35, 36]. The Medication Regimen Complexity Index 
(MRCI) is a frequently used score to predict the complexity 
of the medication regimen. It is based on 65 items and con-
siders dosing frequency, dosage forms and other character-
istics which may influence the complexity [37, 38]. A higher 
MRCI score reflects a more complex medication regime. 
Although a clear association was not established, most stud-
ies show a higher readmission rate when patients have higher 
MRCI [36, 38–40].
Olson et al. investigated if specific older patient popula-
tions are at risk for medication related hospital readmission 
[41]. They found that older men with adult children as car-
egiver seemed to have an increased risk for hospital readmis-
sions [41]. Possible explanations are e.g. difficulties with 
regard to medication adherence due to parents who want to 
maintain their autonomy, or in case of siblings sharing the 
care for parents there could be confusion about the respon-
sibilities. Another explanation is that medication problems 
could be related to informal caregiving itself. More research 
is needed to investigate the reason why males with adult 
children as caregivers show an increased risk for hospital 
readmissions.
Other risk factors which are associated with a higher 
readmission rate are low adherence, experiencing a fall in 
the last 12 months, weight loss and medical error due to 
discontinuity of care from inpatient to outpatient setting 
[42–45]. Table 1 shows the different published risk factors.
Interventions which may reduce the medication 
related readmissions
Different interventions to reduce the risk of medication 
related admissions or readmissions are mentioned in litera-
ture. One of them is the involvement of a pharmacist as part 
of the medical team [46].
The effect of such an intervention is hard to evaluate due 
to the different ways the participation of the pharmacists 
is executed. Furthermore there was great difference in the 
way a patient is involved in his/her medication management 
[46–52].
Overall, studies show a possible benefit with regard to 
participation of a pharmacist, especially in patients with a 
high risk of medication related admissions, but studies show 
great heterogeneity [51, 53, 54].
Different studies investigated whether education could 
improve the medication adherence, because low and inter-
mediate medication adherence is associated with more 
readmissions compared to high medication adherence [42]. 
Some publications show that some interventions increase the 
medication adherence however there is a great heterogeneity 
and not all methods are effective [55].
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Table 1  Risk factors for medication related admissions and medication related readmissions
Risk factor Studied in the following population Found in the studies
High risk medication Adult patients hospitalization at general medicine Allaudeen et al. [44]
50 years old and older and had one of a selection comor-
bidity
Schoonover et al. [39]
Adult patients Willson et al. [38]
Adult patients with heart failure Colavecchia et al. [36]
Polypharmacy Patients 70 years old or older Wimmer et al. [40]
Patients hospitalized in a geriatric unit Cabre et al. [33]
Adult patients McLachlan et al. [23]
Low or intermediate therapy adherence (combined)/non 
adherence
Patients above 65 years old or ten or more medications, 
heart failure, pharmacist consultation of duplications in 
medication list
Rosen et al. [42]
Adult patients Leendertse et al. [7]
Inappropriate medication Patients hospitalized in a geriatric unit Cabre et al. [33]
No pharmacy consult Adult patients Thomas et al. [27]
Work up error/missing follow up appointments Adult patients Moore et al. [45]
Adult patients Thomas et al. [27]
Older age Adult patients Hallgren et al. [43]
Adult patients Leendertse et al. [7]
Adult patients Thomas et al. [27]
Adult patients Davies et al. [25]
Male sex Adult patients Hallgren et al. [43]
Patients 60 years and older Zhang et al. [7]
Female Patients hospitalized in a geriatric unit Cabre et al. [33]
Black race Adult patients hospitalization at general medicine Allaudeen et al. [44]
Comorbidities (including high comorbidity score) Adult patients Hallgren et al. [43]
Adult patients Leendertse et al. [7]
Patients 60 years and older Zhang et al. [24]
Renal disease/—insufficiency Adult patients hospitalization at general medicine Allaudeen et al. [44]
Patients hospitalized in a geriatric unit Cabre et al. [33]
Adult patients Leendertse et al. [7]
Congestive heart failure Adult patients hospitalization at general medicine Allaudeen et al. [44]
Cancer Adult patients hospitalization at general medicine Allaudeen et al. [44]
Patients 65 years old or older Hauviller et al. [28]
Patients 80 years old or older Alassaad et al. [34]
Iron deficiency anemia Adult patients hospitalization at general medicine Allaudeen et al. [44]
Presence of pulmonary disease Patients 80 years old or older Alassaad et al. [34]
Cognitive impairment or dementia Patients 70 years old or older Wimmer et al. [40]
Adult patients Leendertse et al. [7]
Weight loss Adult patients hospitalization at general medicine Allaudeen et al. [44]
Falling in the last 12 months Adult patients Hallgren et al. [43]
Length of stay in the hospital Adult patients Leendertse et al. [7]
Patients 60 years and older Zhang et al. [24]
Discharged to nonhome setting/Depending living situation Patients 70 years old or older Wimmer et al. [40]
Adult patients Leendertse et al. [7]
Elderly men with adult children as caregivers Adult patients Olson et al. [41]
Responsibility Adult patients Hallgren et al. [43]
Feelings of loneliness Adult patients Hallgren et al. [43]
Self-rated health Adult patients Hallgren et al. [43]
Life-Satisfaction Adult patients Hallgren et al. [43]
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Besides education to increase the medication adherences 
different studies investigated whether packaging of the medi-
cation would increase the medication adherence. A meta-
analysis found that packaging intervention increases medica-
tion adherence [56]. As earlier mentioned, high adherence 
is associated with less readmissions, this means that pack-
aging intervention might indirectly lead to less medication 
readmissions.
Different education programmes and transition-of-care 
interventions are used in several studies; most of them show 
lower readmissions. However, these interventions are time 
consuming and the studies show great heterogeneity [55, 
57, 58].
Digital assistance in the form of Clinical Decision Sup-
port Systems (CDSS), is also being investigated as interven-
tion to improve outcome in medication related problems [59, 
60]. CDSS supports the healthcare professional, pharmacist 
and/or physician, in optimizing medication. This system is 
based on a database that generate drug safety alerts for the 
use of medication based on different guidelines/criteria, 
laboratory values and patient characteristics [59, 60].
Studies show that a CDSS can support the professional 
in performing a medication review [59, 61]. The system is 
especially of additional value in recognizing absent medica-
tion when there is a clear indication and when there are con-
tra indications or interactions for medication [59]. Another 
benefit of a CDSS is that the medication is monitored con-
tinuously whereas a manual medication review is performed 
only once or twice a year due to time pressure [59, 60]. 
For example, the renal function changes over time, requir-
ing adjustment of medication which will be immediately 
detected by the CDSS in contrary to manual medication 
review.
Previous studies have shown that the use of CDDS has an 
additional value for the manual medication review [59, 61].
Discussion
The aim of this literature overview was to give an over-
view on what currently is known about medication related 
hospital admissions, medication related hospital readmis-
sions, their risk factors, and possible interventions which 
reduce medication related hospital readmissions. The inci-
dence of medication related hospital admissions shows a 
great variety and ranges between 0.5 and 19.3% and is 
dependant of the definition used in the different studies 
[7, 10, 17–20, 22]. The incidence of medication related 
hospital readmissions has even a broader range, namely 
0.09% up to 64.0% [27–29]. The most important identified 
risk factors for medication related admissions or medica-
tion related readmissions are high risk medication, polyp-
harmacy, therapy nonadherence, older age, comorbidities, 
renal disease, congestive heart failure, cognitive impair-
ment and length of stay in the hospital [7, 23–25, 27, 33, 
36, 38–40, 42–44].
The most common medications associated with (poten-
tially preventable) admissions are anticoagulants, antiplate-
let drugs, vasodilators, psychotropic medications and diuret-
ics [7, 23, 33].
However all of the results show much heterogeneity 
between studies. The study designs and definitions used for 
medication related admissions and medication related read-
missions are different between the studies.
In the included studies, different interventions are investi-
gated such as the involvement of pharmacists in medication 
reviews during the admissions of patients, different educa-
tion programs and transition-care interventions. Some stud-
ies show less medication related readmissions, however 
the results are controversial. Probably due to the different 
methods, study populations and interventions which are 
investigated. For example the involvement of pharmacist in 
medication reviews during an admission is different in the 
selected articles, however overall there is a possible benefit 
with regard to participation of a pharmacist, especially in 
patients with a high risk of medication related admissions. 
Beside the involvement of a pharmacist in the medication 
reviews during the admission, other studies investigated the 
value of the use of CDDS. As mentioned earlier previous 
studies have shown that the use of CDDS has an additional 
value for the manual medication review [59, 61]. But the 
effect on the readmission rate is not known yet.
The limitation of this study is that the review was not 
systematic and the search was limited to the PubMED data-
base. The aim of the study and the search were both broad, 
however we only performed one search. Afterwards it was 
possibly better to specify the aim and to convert the search 
for the more specific aim. With this search used for this 
review we found a lot of articles not related on this subject. 
Possibly we also missed articles on this subject because we 
only performed one search. The strength of this review is 
that this review gives an overview about a topic which is 
important in the daily care. Although there is a great variety 
in results, overall the studies show the importance to get 
more knowledge about this topic to prevent potential pre-
ventable unfavourable outcomes and high healthcare costs.
In the future we want to investigate the additional value 
of the CDSS in medication related hospital readmissions in 
people older than 60 years. Because there is a lack of a defi-
nition in the literature for a medication related admission and 
readmission, we have chosen to select unplanned admissions 
which are possible medication related. The Dutch guideline 
“Polypharmacy in the older patient” includes a trigger list 
that can be used to establish whether an admission is pos-
sibly medication related [62]. The trigger list is mainly based 
on three studies namely the HARM-, IPCI- and Quadret, 
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and presents the most frequent medication related problems 
which can lead to an admission [7, 11, 63, 64].
Patients aged 60 years and older with an unplanned hospi-
tal admission will be included in the study if the unplanned 
hospital admission is assessed to be medication related 
according to the trigger list. Participants will be randomized 
in intervention or control group. In the control group care as 
usual will be continued. In the intervention group a medica-
tion check will be performed weekly using the CDSS. The 
generated alerts/recommendations will be sent to the general 
practitioner and/or home pharmacist. Follow-up will be one 
year.
With the assistance of the CDSS we aim at reducing the 
medication related readmissions from 20 to 15%.
Conclusion
The definition for both medication related hospital admis-
sions and readmissions varies in different studies leading to 
a great incidence range. Several risk factors related to medi-
cation related hospital admissions and/or readmissions have 
been identified: high risk medication, polypharmacy, therapy 
nonadherence, older age, comorbidities, renal disease, con-
gestive heart failure, cognitive impairment and length of stay 
in the hospital. Known interventions that could possibly lead 
to a decrease in medication related hospital readmissions are 
spare being the involvement of a pharmacist, education pro-
grams and transition-care interventions the most mentioned 
ones although controversial results have been reported. More 
research is needed to gather more information on this topic.
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